UA33191A - Method for treatment of depressive-paranoid syndrome in schizophrenia patients - Google Patents
Method for treatment of depressive-paranoid syndrome in schizophrenia patientsInfo
- Publication number
- UA33191A UA33191A UA99010065A UA99010065A UA33191A UA 33191 A UA33191 A UA 33191A UA 99010065 A UA99010065 A UA 99010065A UA 99010065 A UA99010065 A UA 99010065A UA 33191 A UA33191 A UA 33191A
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- depressive
- schizophrenia patients
- paranoid syndrome
- amitriptyline
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 abstract 4
- 229960000836 amitriptyline Drugs 0.000 abstract 2
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 abstract 2
- 229960003878 haloperidol Drugs 0.000 abstract 2
- 238000001962 electrophoresis Methods 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
In 4 h after the oral administration of Haloperidol and Amitriptyline in the morning in the setting of preceding two-week oral administration, the transorbital electrophoresis of 0.5% Haloperidol solution and 1% Amitriptyline solution is performed for 25-30 minutes using two different ocular electrodes with the increment of the current from 2 to 4 mA, the current density from 0.03 to 0.05 mA/cm2, the course of the treatment comprises 15 daily procedures.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA99010065A UA33191A (en) | 1999-01-05 | 1999-01-05 | Method for treatment of depressive-paranoid syndrome in schizophrenia patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA99010065A UA33191A (en) | 1999-01-05 | 1999-01-05 | Method for treatment of depressive-paranoid syndrome in schizophrenia patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA33191A true UA33191A (en) | 2001-02-15 |
Family
ID=74196326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA99010065A UA33191A (en) | 1999-01-05 | 1999-01-05 | Method for treatment of depressive-paranoid syndrome in schizophrenia patients |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA33191A (en) |
-
1999
- 1999-01-05 UA UA99010065A patent/UA33191A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0001309D0 (en) | Valve arrangement | |
| ATE237330T1 (en) | ADMINISTRATION OF NICOTINE IN THE COLON FOR THE TREATMENT OF INFLAMMATORY VITAL DISEASE | |
| ATE295161T1 (en) | ACTIVE MIXTURE IN VAGAL-INDUCED ASYSTOLY | |
| MX9602517A (en) | Naphthylamides as central nervous system agents. | |
| HUP0202776A2 (en) | Use of (+)-tramadol, o-demethyltramadol or(+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for preparation pharmaceutical composition available for treating urinary incontinence | |
| DE69424777D1 (en) | 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS | |
| DE60026883D1 (en) | METHODS AND COMPOSITIONS FOR TREATING PAIN | |
| UA33191A (en) | Method for treatment of depressive-paranoid syndrome in schizophrenia patients | |
| DK1052973T3 (en) | Transmucosal formulations of levosimendan | |
| UA33198A (en) | Method for intensive therapy of schizophrenia | |
| UA33160A (en) | Method for intensive therapy of paranoid schizophrenia | |
| DE60121978D1 (en) | 7-CHLORO-4-HYDROXY-2- (2-PYRIDYLETHYL) -1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BOCHINOLINE-1,10-DIONE AND ITS USE FOR THE TREATMENT OF PAIN | |
| UA33655A (en) | Method for treating simple and paranoid schizophrenia | |
| UA38299A (en) | METHOD OF INTENSIVE THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA | |
| JO2296B1 (en) | Substituted pyrroles | |
| UA33739A (en) | Method for treating continious schizophrenia | |
| UA38381A (en) | METHOD OF COMPLEX THERAPY OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA | |
| UA22240A (en) | Method for complex treatment of patient with paranoid schizophrenia | |
| UA37666A (en) | METHOD OF COMPLEX THERAPY OF SIMPLE SCHIZOPHRENIA WITH SUICIDE BEHAVIOR | |
| UA38484A (en) | METHOD OF INTENSIVE TREATMENT OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA | |
| UA22241A (en) | Method for treatment of patient with paranoid schizophrenia | |
| UA28417A (en) | Method for the auxiliary reflex anaesthetizing | |
| UA19647A (en) | Method for treatment of jaw osteomyelitis | |
| UA41077A (en) | Method for complex treatment of patients with newly diagnosed pulmonary tuberculosis | |
| UA38767A (en) | METHOD OF COMPLEX TREATMENT OF DEPRESSIVE-PARANOID SYNDROME IN PATIENTS WITH SCHIZOPHRENIA |